Primary central nervous system lymphoma: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ | '''For patient information click [[{{PAGENAME}} (patient information)|here]]''' | ||
{{Primary central nervous system lymphoma}} | {{Primary central nervous system lymphoma}} | ||
{{CMG}}{{AE}}{{SR}} | |||
==[[Primary central nervous system lymphoma overview|Overview]]== | ==[[Primary central nervous system lymphoma overview|Overview]]== | ||
Line 47: | Line 41: | ||
[[Category:Viral diseases]] | [[Category:Viral diseases]] | ||
[[Category:Oncology]] | [[Category:Oncology]] | ||
[[id:Limfoma susunan saraf pusat]] | [[id:Limfoma susunan saraf pusat]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} |
Revision as of 16:28, 17 February 2016
For patient information click here
Primary central nervous system lymphoma Microchapters |
Differentiating Primary Central Nervous System Lymphoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Primary central nervous system lymphoma On the Web |
American Roentgen Ray Society Images of Primary central nervous system lymphoma |
Directions to Hospitals Treating Primary central nervous system lymphoma |
Risk calculators and risk factors for Primary central nervous system lymphoma |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Primary central nervous system lymphoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | CT | MRI | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies